https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab Mynewsdesk RSS - Press releases, News, and Blog Posts. https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab https://www.mynewsdesk.com/assets/graphics/logos/logo-small-9892f98564f91864075bd14001f8470f2f9bf254729c37044b4b1ac9b0db6b40.png 128 23 en 15 Wed, 14 Jan 2026 07:00:00 +0100 Oslo, 14.01.2026 – FrostPharma today announces that Silarosa (lisdexamfetamine oral solution) is now available in Norway. The medication offers a personalized treatment option for children and adolescents with ADHD who have difficulty swallowing tablets or capsules. https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/pressreleases/new-adhd-medication-in-norway-3425785?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/pressreleases/new-adhd-medication-in-norway-3425785?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Anthrop Pharmaceuticals AB Mon, 13 Oct 2025 07:00:00 +0200 https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/pressreleases/desivon-klassikern-aer-tillbaka-paa-svenska-apotek-3409904?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/pressreleases/desivon-klassikern-aer-tillbaka-paa-svenska-apotek-3409904?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Anthrop Pharmaceuticals AB Mon, 29 Sep 2025 14:22:52 +0200 FrostPharma fortsätter tillväxtresan – Magnus Nylén ny VD/ FrostPharma Continues Its Growth Journey – Magnus Nylén Appointed New CEO https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/news/magnus-nylen-ny-vd-slash-magnus-nylen-new-ceo-501549?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/news/magnus-nylen-ny-vd-slash-magnus-nylen-new-ceo-501549?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Anthrop Pharmaceuticals AB Mon, 29 Sep 2025 09:00:00 +0200 FrostPharma fortsätter tillväxtresan – Magnus Nylén ny VD https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/pressreleases/magnus-nylen-ny-vd-slash-magnus-nylen-new-ceo-3407067?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/pressreleases/magnus-nylen-ny-vd-slash-magnus-nylen-new-ceo-3407067?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Anthrop Pharmaceuticals AB Mon, 15 Sep 2025 09:00:00 +0200 Our Country Manager Finland, Anne Jääskeläinen, participated in a cycling journey with Team Rynkeby to raise vital funds for children with cancer. https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/pressreleases/proud-to-support-annes-journey-with-team-rynkeby-3404310?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/pressreleases/proud-to-support-annes-journey-with-team-rynkeby-3404310?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Anthrop Pharmaceuticals AB Tue, 02 Sep 2025 08:00:00 +0200 FrostPharma lanserar ny hemsida – med förbättrad design, funktion och innehåll för vård och samarbetspartners https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/pressreleases/frostpharma-lanserar-ny-hemsida-med-foerbaettrad-design-funktion-och-innehaall-foer-vaard-och-samarbetspartners-3402060?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/pressreleases/frostpharma-lanserar-ny-hemsida-med-foerbaettrad-design-funktion-och-innehaall-foer-vaard-och-samarbetspartners-3402060?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Anthrop Pharmaceuticals AB Mon, 14 Jul 2025 07:00:00 +0200 https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/pressreleases/frostpharma-tillgaengliggoer-cefixime-frostpharma-i-sverige-3396536?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/pressreleases/frostpharma-tillgaengliggoer-cefixime-frostpharma-i-sverige-3396536?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Anthrop Pharmaceuticals AB Fri, 31 May 2024 10:00:00 +0200 FrostPharma was founded late 2016 and have since grown significantly, the vision is to become a leading specialty pharma company. We are now happy to announce that FrostPharma take another step towards their vision by receiving the distribution rights from Diurnal Limited, a Neurocrine Biosciences company, in the Nordics for Efmody® (hydrocortisone modified-release hard capsules). https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/pressreleases/frostpharma-receives-the-distribution-rights-for-efmody-r-in-the-nordics-in-may-2024-3326410?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/pressreleases/frostpharma-receives-the-distribution-rights-for-efmody-r-in-the-nordics-in-may-2024-3326410?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Anthrop Pharmaceuticals AB Fri, 08 Mar 2024 12:35:40 +0100 I samband med internationella kvinnodagen den 8 mars, som har temat ”Inspire inclusion”, vill vi på FrostPharma inspirera genom att dela med oss av vår jämställdhetskultur, där alla har samma förutsättningar att växa och bidra. Det har genererat en jämställd organisation inom alla nivåer av företaget och bidrar till ökande tillväxt. https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/pressreleases/frostpharmas-jaemstaelldhetskultur-bidrar-till-tillvaext-3308974?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/pressreleases/frostpharmas-jaemstaelldhetskultur-bidrar-till-tillvaext-3308974?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Anthrop Pharmaceuticals AB Mon, 19 Feb 2024 16:19:21 +0100 https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/pressreleases/frostpharma-enters-the-hematology-area-in-the-nordics-3304665?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/pressreleases/frostpharma-enters-the-hematology-area-in-the-nordics-3304665?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Anthrop Pharmaceuticals AB Thu, 01 Feb 2024 09:59:00 +0100 Apotek Produktion & Laboratorier inleder ett samarbete med FrostPharma, som tillhandahåller WoodSafe® riskavfallskärl, för att minska sin klimatpåverkan och bidra till ett mer hållbart samhälle. Ett byte av traditionella riskavfallskärl tillverkade i fossil-baserad plast till nya generations kärl av förnybart material ger minskade CO2-utsläpp med 66%. https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/pressreleases/woodsafe-tillsammans-med-svenska-laekemedelstillverkaren-apl-bidrar-till-en-groenare-haelso-och-sjukvaard-3300874?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/pressreleases/woodsafe-tillsammans-med-svenska-laekemedelstillverkaren-apl-bidrar-till-en-groenare-haelso-och-sjukvaard-3300874?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Anthrop Pharmaceuticals AB Fri, 16 Jun 2023 13:55:37 +0200 Priveq investerar i FrostPharma FrostPharma, ett entreprenöriellt läkemedelsbolag inriktade på att kommersialisera värdeskapande specialist- och sjukhusläkemedel samt utveckla hållbara förbrukningsprodukter för hälso- och sjukvården, välkomnar Priveq Investment (”Priveq”) som ny tillväxtpartner. https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/pressreleases/priveq-investerar-i-frostpharma-3260063?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/pressreleases/priveq-investerar-i-frostpharma-3260063?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Anthrop Pharmaceuticals AB Mon, 03 Apr 2023 10:00:00 +0200 FrostPharma strengthen its product portfolio in the Nordics by including Betapred (betametasone) from the 1st of April, 2023. https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/pressreleases/frostpharma-strengthen-its-product-portfolio-with-betapred-3243852?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/pressreleases/frostpharma-strengthen-its-product-portfolio-with-betapred-3243852?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Anthrop Pharmaceuticals AB Tue, 14 Feb 2023 14:19:50 +0100 WoodSafe was nominated and selected as Catalyst company 2023 within the Impact category! https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/pressreleases/woodsafe-catalyst-company-2023-within-the-impact-category-3233749?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/pressreleases/woodsafe-catalyst-company-2023-within-the-impact-category-3233749?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Anthrop Pharmaceuticals AB Tue, 10 Jan 2023 14:24:50 +0100 FrostPharma is now further strengthening the organization through the recruitment of Rebecka Grund as COO. https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/pressreleases/frostpharma-is-now-further-strengthening-the-organization-through-the-recruitment-of-rebecka-grund-as-coo-3226852?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/pressreleases/frostpharma-is-now-further-strengthening-the-organization-through-the-recruitment-of-rebecka-grund-as-coo-3226852?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Anthrop Pharmaceuticals AB Tue, 21 Jun 2022 11:01:22 +0200 WoodSafe® är en ny serie innovativa riskavfallskärl i biokompositmaterial baserat på sågspån och returplast. Ett byte från dagens kärl i fossil plast, till WoodSafe® i biokompositmaterial, skulle reducera CO2-utsläppen med över 50% enligt LCA-analys. https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/blog_posts/ett-enkelt-byte-som-goer-stor-skillnad-foer-miljoen-108804?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/blog_posts/ett-enkelt-byte-som-goer-stor-skillnad-foer-miljoen-108804?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Anthrop Pharmaceuticals AB Fri, 10 Jun 2022 11:30:00 +0200 FrostPharma lanserar nu WoodSafe®, en ny serie innovativa riskavfallsbehållare i biokomposit som reducerar CO2-utsläppen med över 50%. Av plastbaserade produkter utgör dagens medicinska riskavfallsbehållare den tredje största koldioxidboven inom hälso- och sjukvården. https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/pressreleases/woodsafe-r-riskavfallsbehaallare-halverar-co2-utslaeppen-3188054?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/pressreleases/woodsafe-r-riskavfallsbehaallare-halverar-co2-utslaeppen-3188054?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Anthrop Pharmaceuticals AB Tue, 01 Feb 2022 08:56:12 +0100 FrostPharma ENTERS AGREEMENT WITH ADVICENNE FOR MARKETING AND DISTRIBUTION OF SIBNYAL® IN the NORDIC REGION Under the terms of the agreement, FrostPharma will receive the exclusive rights to distribute and market Sibnayal® for the treatment of distal renal tubular acidosis (dRTA) in the Nordic countries including Denmark, Finland, Norway, Iceland and Sweden. See press release for details. https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/pressreleases/frostpharma-enters-agreement-with-advicenne-for-marketing-and-distribution-of-sibnyal-r-in-the-nordic-region-3153732?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/pressreleases/frostpharma-enters-agreement-with-advicenne-for-marketing-and-distribution-of-sibnyal-r-in-the-nordic-region-3153732?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Anthrop Pharmaceuticals AB Mon, 03 Jan 2022 09:00:00 +0100 During her tenure as CEO for FrostPharma AB, Cecilia Bröms-Thell has invested and prepared the FrostPharma business for accelerated growth while securing solid performance of the in-line portfolio. The Regulatory framework and the Commercial capabilities have been strengthened and FrostPharma is now in a position to From the 1st of January 2022 Fredrik Andersch take the role of FrostPharma CEO. https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/news/frostpharma-organisation-announcement-440217?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/news/frostpharma-organisation-announcement-440217?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Anthrop Pharmaceuticals AB Fri, 08 Oct 2021 13:27:18 +0200 Det är inte bara på kontoret som vi vill värna om miljön genom smarta val. Vi är även måna om att hela vårt arbetssätt genomsyras av hållbarhet, och att hela produktionskedjan är så klimateffektiv som möjligt- från början till slut. Läs om våra långsiktiga mål för att uppfylla detta. https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/blog_posts/laangsiktiga-maal-foer-ett-klimatsmart-arbetssaett-103778?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/anthrop-pharmaceuticals-ab/blog_posts/laangsiktiga-maal-foer-ett-klimatsmart-arbetssaett-103778?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Anthrop Pharmaceuticals AB